Rosamund Wilson

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

Thomas Voit, Haluk Topaloğlu, Volker Straub et al. · The Lancet Neurology · 2014 · 295 citations

Medicine, Pharmacology, Pharmacotherapy +5

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

Steven E. Nissen, Kathy Wolski, Craig Balog et al. · JAMA · 2022 · 283 citations · Full text

Medicine, Cardiology, Pharmacology +16

Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial

Stephan Weidinger, Thomas Bieber, Michael J. Cork et al. · British Journal of Dermatology · 2023 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Preclinical development of CAT‐354, an IL‐13 neutralizing antibody, for the treatment of severe uncontrolled asthma

PD Monk, E. Suzanne Cohen, de Villena Fernando Pardo Manuel et al. · British Journal of Pharmacology · 2011 · 103 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Predicting survival from out-of-hospital cardiac arrest: a multivariate analysis

Clive Weston, Rosamund Wilson, Sian D. Jones · Resuscitation · 1997 · 90 citations

Public Health, Biostatistics, Cardiology +12